한글목차

심장 절제의 동향과 전망

세계 심장 절제 시장은 2024년부터 2030년까지 13.0%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 약 89억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 심혈관 환자 인구 증가, 의료 인프라의 개선으로 인해 더 나은 의료 서비스에 대한 인식이 높아지고, 좌식 생활 방식의 채택이 증가하고 있다는 점입니다. 세계 심장 절제 시장의 미래는 수술센터, 심장 센터 및 병원 시장에서의 기회로 인해 유망합니다.

심장 절제 시장 인사이트

Lucintel의 예측에 따르면, 전기 절제기는 만성 심장 질환을 치료하기 위한 첨단 치료 기술의 채택이 증가함에 따라 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

이 시장에서 심장 센터는 효과적인 치료 솔루션을 찾기 위해 신흥 경제 국가에서 도입이 증가함에 따라 가장 큰 시장 부문이 될 것입니다.

아시아태평양은 고령 인구의 급격한 증가, 심혈관 질환의 유병률 증가, 이 지역의 헬스케어 부문의 성장으로 인해 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 향후 성장이 가속화될 부문과 그 이유는?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 심장 절제 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 심장 절제 시장 동향(2018-2023)과 예측(2024-2030)
• 제품별 세계의 심장 절제 시장
  • 무선 주파수
  • 절제 장치
  • 전기 절제 장치
  • 냉동 절제 장치
  • 초음파 절제기
• 접근 방식별 세계의 심장 절제 시장
  • 카테터 기반
  • 절개/외과용
• 최종 용도별 세계의 심장 절제 시장
  • 외과 센터
  • 심장 중추
  • 병원
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018-2030년)

• 지역별 세계의 심장 절제 시장
• 북미의 심장 절제 시장
• 유럽의 심장 절제 시장
• 아시아태평양의 심장 절제 시장
• 기타 지역의 심장 절제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계의 심장 절제 시장 성장 기회
  • 접근 방식별 세계의 심장 절제 시장 성장 기회
  • 최종 용도별 세계의 심장 절제 시장 성장 기회
  • 지역별 세계의 심장 절제 시장 성장 기회
• 세계 심장 절제 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 심장 절제 시장 능력 확대
  • 세계 심장 절제 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• lcon Laboratories
• Advanced Cardiac Therapeutics
• Angiodynamics
• Atricure
• Biosense Webster
• Boston Scientific Corporation
• Conmed Corporation
• Medtronic
• Olympus Corporation

영문목차

Cardiac Ablation Trends and Forecast

The future of the global cardiac ablation market looks promising with opportunities in the surgical center, cardiac center, and hospital markets. The global cardiac ablation market is expected to reach an estimated $8.9 billion by 2030 with a CAGR of 13.0% from 2024 to 2030. The major drivers for this market are large population base of cardiovascular patients, increasing awareness about better healthcare services with improving healthcare infrastructure, and growing adoption of sedendary lifestyle.

A more than 150-page report is developed to help in your business decisions.

Cardiac Ablation by Segment

The study includes a forecast for the global cardiac ablation by product, approach, end use, and region.

Cardiac Ablation Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Radiofrequency
• Ablators
• Electrical Ablators
• Cryoablation Devices
• Ultrasound Ablators

Cardiac Ablation Market by Approach [Shipment Analysis by Value from 2018 to 2030]:

• Catheter-Based
• Open/Surgical

Cardiac Ablation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Surgical Centers
• Cardiac Centers
• Hospitals
• Others

Cardiac Ablation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cardiac Ablation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac ablation companies profiled in this report include-

• Icon Laboratories
• Advanced Cardiac Therapeutics
• Angiodynamics
• Atricure
• Biosense Webster
• Boston Scientific Corporation
• Conmed Corporation
• Medtronic
• Olympus Corporation

Cardiac Ablation Market Insights

Lucintel forecasts that electrical ablators is expected to witness highest growth over the forecast period due to growing adoption of advanced therapeutic procedures to treat chronic cardiac disease.

Within this market, cardiac centers will remain the largest segment due to rising deployment across developing economies for effective treatment solutions.

APAC is expected to witness highest growth over the forecast period due to surge in geriatric population, rising prevalence of cardiovascular diseases, and growing healthcare sector in the region.

Features of the Global Cardiac Ablation Market

Market Size Estimates: Cardiac ablation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac ablation market size by product, approach, end use, and region in terms of value ($B).

Regional Analysis: Cardiac ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, approachs, end uses, and regions for the cardiac ablation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac ablation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cardiac ablation market size?

Answer: The global cardiac ablation market is expected to reach an estimated $8.9 billion by 2030.

Q2. What is the growth forecast for cardiac ablation market?

Answer: The global cardiac ablation market is expected to grow with a CAGR of 13.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the cardiac ablation market?

Answer: The major drivers for this market are large population base of cardiovascular patients, increasing awareness about better healthcare services with improving healthcare infrastructure, and growing adoption of sedendary lifestyle.

Q4. What are the major segments for cardiac ablation market?

Answer: The future of the cardiac ablation market looks promising with opportunities in the surgical center, cardiac center, and hospital markets.

Q5. Who are the key cardiac ablation market companies?

Answer: Some of the key cardiac ablation companies are as follows:

• Icon Laboratories
• Advanced Cardiac Therapeutics
• Angiodynamics
• Atricure
• Biosense Webster
• Boston Scientific Corporation
• Conmed Corporation
• Medtronic
• Olympus Corporation

Q6. Which cardiac ablation market segment will be the largest in future?

Answer: Lucintel forecasts that electrical ablators is expected to witness highest growth over the forecast period due to growing adoption of advanced therapeutic procedures to treat chronic cardiac disease.

Q7. In cardiac ablation market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to surge in geriatric population, rising prevalence of cardiovascular diseases, and growing healthcare sector in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cardiac ablation market by product (radiofrequency, ablators, electrical ablators, cryoablation devices, and ultrasound ablators), approach (catheter-based and open/surgical), end use (surgical centers, cardiac centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Ablation Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Cardiac Ablation Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Cardiac Ablation Market by Product
  • 3.3.1: Radiofrequency
  • 3.3.2: Ablators
  • 3.3.3: Electrical Ablators
  • 3.3.4: Cryoablation Devices
  • 3.3.5: Ultrasound Ablators
• 3.4: Global Cardiac Ablation Market by Approach
  • 3.4.1: Catheter-Based
  • 3.4.2: Open/Surgical
• 3.5: Global Cardiac Ablation Market by End Use
  • 3.5.1: Surgical Centers
  • 3.5.2: Cardiac Centers
  • 3.5.3: Hospitals
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Cardiac Ablation Market by Region
• 4.2: North American Cardiac Ablation Market
  • 4.2.2: North American Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
• 4.3: European Cardiac Ablation Market
  • 4.3.1: European Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
  • 4.3.2: European Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
• 4.4: APAC Cardiac Ablation Market
  • 4.4.1: APAC Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
  • 4.4.2: APAC Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others
• 4.5: ROW Cardiac Ablation Market
  • 4.5.1: ROW Cardiac Ablation Market by Product: Radiofrequency, Ablators, Electrical Ablators, Cryoablation Devices, and Ultrasound Ablators
  • 4.5.2: ROW Cardiac Ablation Market by End Use: Surgical Centers, Cardiac Centers, Hospitals, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cardiac Ablation Market by Product
  • 6.1.2: Growth Opportunities for the Global Cardiac Ablation Market by Approach
  • 6.1.3: Growth Opportunities for the Global Cardiac Ablation Market by End Use
  • 6.1.4: Growth Opportunities for the Global Cardiac Ablation Market by Region
• 6.2: Emerging Trends in the Global Cardiac Ablation Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cardiac Ablation Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Ablation Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: lcon Laboratories
• 7.2: Advanced Cardiac Therapeutics
• 7.3: Angiodynamics
• 7.4: Atricure
• 7.5: Biosense Webster
• 7.6: Boston Scientific Corporation
• 7.7: Conmed Corporation
• 7.8: Medtronic
• 7.9: Olympus Corporation